Eva Hellström‐Lindberg

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati et al. · Blood · 2013 · 1.8K citations

Life Sciences, Genetics, Molecular Genetics +16

Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts

Elli Papaemmanuil, Mario Cazzola, Jacqueline Boultwood et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Luca Malcovati, Elli Papaemmanuil, David Bowen et al. · Blood · 2011 · 494 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

Eva Hellström‐Lindberg, Robert S. Negrin, Richard S. Stein et al. · British Journal of Haematology · 1997 · 314 citations

Medicine, Hematology, Pharmacotherapy +14

Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome

Martin Jädersten, Luca Malcovati, Ingunn Dybedal et al. · Journal of Clinical Oncology · 2008 · 297 citations · Full text

Medicine, Hematology, Chemotherapy +13